Hydrochlorothiazide vs Doxazosin

Hydrochlorothiazide wins for rapid, predictable subcutaneous water loss (peak week drying), long-term BP management with minimal orthostatic side effects, and simple titration schedules. Its ceiling effect protects against catastrophic electrolyte losses seen in loop diuretics, making it the go-to for physique-focused dry-outs and low-complexity BP protocols.

Doxazosin wins for situations where additional blood pressure lowering is needed beyond an ARB or ACE inhibitor, especially when sympathetic overdrive, nocturnal blood pressure spikes, or AAS-driven urinary symptoms are an issue. Its alpha-1 blockade also addresses AAS-induced BPH and sleep fragmentation where thiazides offer no relief. The long half-life supports once-nightly admin to minimize orthostatic hypotension risk during waking hours.

Pick Hydrochlorothiazide if:

• Protocol calls for a cosmetic dry-out during peak week prepping for photos, stage, or rapid tightening
• Reliable diuretic action is needed with a controllable safety profile and minimal rebound risk
• A low-complexity BP tool is preferred, especially in combination with telmisartan
• Electrolyte depletion risk needs to be minimized compared to loops
• Long-term blood pressure support is the primary research goal

Pick Doxazosin if:

• Protocol needs to stack an adjunct antihypertensive when ARB/ACE alone isn't enough during high-risk cycles (e.g., tren, heavy orals)
• Research goal involves managing AAS-induced BPH, nocturia, or lower urinary tract symptoms
• Addressing tren-induced insomnia or sympathetic overdrive is a priority (alpha-1 blockade can help with sleep)
• Orthostatic hypotension can be managed with bedtime administration
• A flexible agent that covers both BP and some side effects of harsh cycles is needed